Merck Sharp & Dohme Corp.'s Net Worth
$1.18 Billion
Who is Merck Sharp & Dohme Corp.?
Merck Sharp & Dohme Corp. has an estimated net worth of $1.18 Billion. This is based on reported shares across multiple companies, which include OPGEN INC, BeiGene, Ltd., ARQULE INC, NGM BIOPHARMACEUTICALS INC, SUTRO BIOPHARMA INC, and Menlo Therapeutics Inc..
SEC CIK
Merck Sharp & Dohme Corp.'s CIK is 0000942443
Past Insider Trading and Trends
2016 was Merck Sharp & Dohme Corp.'s most active year for acquiring shares with 8 total transactions. Merck Sharp & Dohme Corp.'s most active month to acquire stocks was the month of January. 2016 was Merck Sharp & Dohme Corp.'s most active year for disposing of shares, totalling 2 transactions. Merck Sharp & Dohme Corp.'s most active month to dispose stocks was the month of January. 2019 saw Merck Sharp & Dohme Corp. paying a total of $65,946,928.00 for 12,955,016 shares, this is the most they've acquired in one year. In 2018 Merck Sharp & Dohme Corp. cashed out on 74,794,315 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
OPGEN INC (OPGN) Snapshot price: $0.36
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +102.07% | 2.73M |
—
|
—
| 5.41M |
Jun 27
| |||
Form 4
| +81.13% | 1.2M |
—
|
—
| 2.68M |
May 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
BeiGene, Ltd. (BGNE) Snapshot price: $153.58
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 31.59M |
—
|
—
| 31.59M |
Feb 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
ARQULE INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
NGM BIOPHARMACEUTICALS INC (NGM) Snapshot price: $1.42
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 12.96M |
$16.00 |
—
| 12.96M |
Apr 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
SUTRO BIOPHARMA INC (STRO) Snapshot price: $4.685
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.72M |
$15.00 |
—
| 2.72M |
Oct 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |